Cargando…

Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity

Ergosterol biosynthesis inhibitors, such as posaconazole and ravuconazole, have been proposed as drug candidates for Chagas disease, a neglected infectious tropical disease caused by the protozoan parasite Trypanosoma cruzi. To understand better the mechanism of action and resistance to these inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franco, Caio H., Warhurst, David C., Bhattacharyya, Tapan, Au, Ho Y.A., Le, Hai, Giardini, Miriam A., Pascoalino, Bruno S., Torrecilhas, Ana Claudia, Romera, Lavinia M.D., Madeira, Rafael Pedro, Schenkman, Sergio, Freitas-Junior, Lucio H., Chatelain, Eric, Miles, Michael A., Moraes, Carolina B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369355/ https://www.ncbi.nlm.nih.gov/pubmed/32688218 http://dx.doi.org/10.1016/j.ijpddr.2020.06.001

Ejemplares similares

Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and development
por: Moraes, Carolina B., et al.
Publicado: (2014)

Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51
por: Gunatilleke, Shamila S., et al.
Publicado: (2012)

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit
por: Chen, Chiung-Kuang, et al.
Publicado: (2009)

Structural Characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei Bound to the Antifungal Drugs Posaconazole and Fluconazole
por: Chen, Chiung-Kuang, et al.
Publicado: (2010)

Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51
por: Vieira, Debora F., et al.
Publicado: (2014)

Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
por: Dauchy, Frédéric-Antoine, et al.
Publicado: (2016)

4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruzi Drug Leads with Improved Pharmacokinetic Profile and in Vivo Potency
por: Calvet, Claudia M., et al.
Publicado: (2014)

Correction: Trypanosoma brucei CYP51: Essentiality and Targeting Therapy in an Experimental Model
Publicado: (2017)

Point Mutations in the 14-α Sterol Demethylase Cyp51A or Cyp51C Could Contribute to Azole Resistance in Aspergillus flavus
por: Lucio, Jose, et al.
Publicado: (2020)

Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi
por: Celia-Sanchez, Brandi N, et al.
Publicado: (2022)

Development of a Fluorescence-based Trypanosoma cruzi CYP51 Inhibition Assay for Effective Compound Triaging in Drug Discovery Programmes for Chagas Disease
por: Riley, Jennifer, et al.
Publicado: (2015)

Polymorphisms of CYP51A1 from Cholesterol Synthesis: Associations with Birth Weight and Maternal Lipid Levels and Impact on CYP51 Protein Structure
por: Lewińska, Monika, et al.
Publicado: (2013)

A Cyp51B Mutation Contributes to Azole Resistance in Aspergillus fumigatus
por: Gonzalez-Jimenez, Irene, et al.
Publicado: (2020)

Drug Strategies Targeting CYP51 in Neglected Tropical Diseases
por: Choi, Jun Yong, et al.
Publicado: (2014)

Heterologous expression of the Monilinia fructicola CYP51 (MfCYP51) gene in Pichia pastoris confirms the mode of action of the novel fungicide, SYP-Z048
por: Chen, Fengping, et al.
Publicado: (2015)

4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection
por: Calvet, Claudia Magalhaes, et al.
Publicado: (2017)

Study of Azole - Resistant and Cyp51a Gene in Aspergillus Fumigatus
por: Zarrin, Majid, et al.
Publicado: (2018)

The Fungal CYP51s: Their Functions, Structures, Related Drug Resistance, and Inhibitors
por: Zhang, Jingxiang, et al.
Publicado: (2019)

Molecular Dynamics Investigations of Binding Mechanism for Triazoles Inhibitors to CYP51
por: Shi, Na, et al.
Publicado: (2020)

Widespread Occurrence of a CYP51A Pseudogene in Calonectria pseudonaviculata
por: Stravoravdis, Stefanos, et al.
Publicado: (2019)

CYP51 Paralogue Structure Is Associated with Intrinsic Azole Resistance in Fungi
por: Van Rhijn, N., et al.
Publicado: (2021)

Azole Antifungal Sensitivity of Sterol 14α-Demethylase (CYP51) and CYP5218 from Malassezia globosa
por: Warrilow, Andrew G. S., et al.
Publicado: (2016)

CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
por: Debnath, Anjan, et al.
Publicado: (2017)

Identification and Analysis of CYP7A1, CYP17A1, CYP20A1, CYP27A1 and CYP51A1 in Cynomolgus Macaques
por: UNO, Yasuhiro, et al.
Publicado: (2014)

The in vivo and in vitro roles of Trypanosoma cruzi Rad51 in the repair of DNA double strand breaks and oxidative lesions
por: Gomes Passos Silva, Danielle, et al.
Publicado: (2018)

Transformation of berberine to its demethylated metabolites by the CYP51 enzyme in the gut microbiota
por: Zhang, Zheng-Wei, et al.
Publicado: (2021)

The recombinase Rad51 plays a key role in events of genetic exchange in Trypanosoma cruzi
por: Alves, Ceres Luciana, et al.
Publicado: (2018)

Stress Induces Release of Extracellular Vesicles by Trypanosoma cruzi Trypomastigotes
por: Vasconcelos, Camilla Ioshida, et al.
Publicado: (2021)

Interactions of antiparasitic sterols with sterol 14α-demethylase (CYP51) of human pathogens
por: Warfield, Jasmine, et al.
Publicado: (2014)

Differentiation of Aspergillus flavus from Aspergillus oryzae Targeting the cyp51A Gene
por: Nargesi, Sanaz, et al.
Publicado: (2021)

Exploring Cryptococcus neoformans CYP51 and Its Cognate Reductase as a Drug Target
por: Ruma, Yasmeen N., et al.
Publicado: (2022)

Characterisation of Candida parapsilosis CYP51 as a Drug Target Using Saccharomyces cerevisiae as Host
por: Ruma, Yasmeen N., et al.
Publicado: (2022)

Azole Resistance-Associated Regulatory Motifs within the Promoter of cyp51A in Aspergillus fumigatus
por: Kühbacher, Alexander, et al.
Publicado: (2022)

Trypanosoma cruzi lineage-specific serology: new rapid tests for resolving clinical and ecological associations
por: Bhattacharyya, Tapan, et al.
Publicado: (2019)

The CYP51F1 Gene of Leptographium qinlingensis: Sequence Characteristic, Phylogeny and Transcript Levels
por: Dai, Lulu, et al.
Publicado: (2015)

Hidden Disease Susceptibility and Sexual Dimorphism in the Heterozygous Knockout of Cyp51 from Cholesterol Synthesis
por: Lewinska, Monika, et al.
Publicado: (2014)

Identification of liver CYP51 as a gene responsive to circulating cholesterol in a hamster model
por: Huang, Haiqiu, et al.
Publicado: (2016)

Evaluation of Selected CYP51A1 Polymorphisms in View of Interactions with Substrate and Redox Partner
por: Režen, Tadeja, et al.
Publicado: (2017)

Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens
por: Novak-Frazer, Lilyann, et al.
Publicado: (2020)

Uncovering New Mutations Conferring Azole Resistance in the Aspergillus fumigatus cyp51A Gene
por: Chen, Peiying, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jj2i2tb0s45i9k6s7262m4i35r